Quetiapine Augmentation for Primary Anxiety Disorder or Mood Disorders With Co-morbid Anxiety Symptoms

Clinical trial NCT00912535 · COMPLETED

Trial details

NCT number: NCT00912535
Sponsor: Chang Gung Memorial Hospital
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Primary Anxiety Disorders Mood Disorders With Comorbid Anxiety Symptoms

Start date: 2009-05-01
Primary completion: 2010-07-01
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.